BUSINESS OPPORTUNITIES.

In Licensing

KLab The strong equity of KLAB can be used for marketing products in India through the sales and marketing teams of KLAB. KLAB current focus is in General Physicians, Gastroenterologists, Orthopaedicians, Surgeons, Pediatricians, Cardiologists, Chest Physicians, ENT surgeons, Gynaecologists and Oncologists.

Present

New Facility In Uttaranchal As Per Latest USFDA guidelines. Manufacturing Unit for General Tablets and Cephalosporin tablets with full Excise Duty and Sales Tax benefits.

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

Patents

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

Out Licensing

KLab can out-license its patented products

Oncology

KLab can provide Oncology Formulations and API’s for the developing countries

Other Formulations

KLab can provide its formulations for marketing into the developing countries

Contract Manufacturing

KLab can provide Contract Manufacturing for Oncology and General products for the Developing Countries

Proof of Concept Studies

KLab can provide speedy in-vitro, in-vivo and clinical trials through capable investigators in Rural State of Art Hospitals.

API’s

KLab can sell its niche API’s for the developing countries.

K-Chirals

KLab can provide Chiral Intermediates.

Scientists

KLab provides funding and strategic advice to innovative scientists with Intellectual Property. KLab provides its research networks and infrastructure to facilitate Intellectual Property development and Management.